The State of Texas Top Legal Officer Files Lawsuit Against Tylenol Producers Concerning Autism Spectrum Assertions

Legal Proceedings
The Texas Attorney General, a Trump ally campaigning for the United States Senate, accused pharmaceutical manufacturers of withholding the risks of acetaminophen

Texas Attorney General Ken Paxton is suing the producers of acetaminophen, alleging the corporations hid safety concerns that the drug created to children's cognitive development.

The lawsuit follows a month after Former President Trump promoted an unverified association between using acetaminophen - also known as acetaminophen - throughout gestation and autism spectrum disorder in offspring.

The attorney general is filing suit against J&J, which formerly manufactured the drug, the sole analgesic recommended for pregnant women, and Kenvue, which now manufacturers it.

In a statement, he said they "deceived the public by profiting off of discomfort and pushing pills regardless of the risks."

The manufacturer asserts there is no credible evidence tying Tylenol to autism spectrum disorder.

"These corporations misled for generations, knowingly endangering countless individuals to boost earnings," Paxton, a Republican, said.

The company said in a statement that it was "seriously troubled by the spread of false claims on the security of acetaminophen and the likely effects that could have on the welfare of US mothers and children."

On its online platform, Kenvue also stated it had "continuously evaluated the pertinent research and there is no credible data that shows a proven link between consuming paracetamol and autism."

Organizations representing physicians and healthcare providers share this view.

The leading OB-GYN organization has declared paracetamol - the primary component in Tylenol - is a restricted selection for women during pregnancy to address discomfort and fever, which can pose significant medical dangers if left untreated.

"In more than two decades of studies on the use of acetaminophen in pregnancy, no reliable research has conclusively proven that the use of acetaminophen in any stage of gestation leads to neurological conditions in young ones," the group said.

The lawsuit cites current declarations from the previous government in asserting the medication is reportedly hazardous.

Last month, Trump raised alarms from medical authorities when he advised pregnant women to "fight like hell" not to consume Tylenol when unwell.

The FDA then issued a notice that medical professionals should consider limiting the use of Tylenol, while also mentioning that "a causal relationship" between the medication and autism spectrum disorder in children has not been proven.

The Health Department head RFK Jr, who supervises the Food and Drug Administration, had promised in spring to initiate "a massive testing and research effort" that would establish the origin of autism in a limited time.

But experts warned that finding a sole reason of autism - thought by researchers to be the outcome of a intricate combination of inherited and external influences - would prove challenging.

Autism spectrum disorder is a type of enduring cognitive variation and condition that impacts how persons perceive and relate to the environment, and is diagnosed using physician assessments.

In his court filing, the attorney general - aligned with the former president who is campaigning for the Senate - asserts Kenvue and Johnson & Johnson "deliberately disregarded and sought to suppress the science" around acetaminophen and autism.

This legal action attempts to require the firms "destroy any marketing or advertising" that asserts Tylenol is safe for women during pregnancy.

The Texas lawsuit parallels the concerns of a group of guardians of children with autism and ADHD who took legal action against the makers of acetaminophen in two years ago.

The court threw out the legal action, declaring studies from the parents' expert witnesses was not conclusive.

Emily Davis
Emily Davis

Lena is a passionate writer and tech enthusiast with a background in digital media, sharing her expertise to help readers navigate daily challenges.